← SynDRA
GINSENOSIDE RG1
SynDRA canonical compound SYN0011021 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | SLCO1B3 |
| Mechanism of action | solute carrier family member inhibitor |
| Indication | alzheimer's disease |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- solute carrier family member inhibitor
Drug classes
- Central Nervous System Agents
Cross-references
Synonyms
- Sanchinoside C1
- Panaxoside A
- Ginsenoside A2
- Panaxoside Rg1
- Sanchinoside Rg1
- PJ788634QY
- CHEBI:67987
- RefChem:37717
- DTXCID701373437
- ginsenoside-Rg(1)
- sanchinoside C(1)
- MFCD00210293
- GinsenosideRG1
- (20S)-ginsenoside Rg1
- Ginsenoside g1
- Panaxoside A;Panaxoside Rg1
- UNII-PJ788634QY
- YURJSTAIMNSZAE-HHNZYBFYSA-N
- Ginsenoside Rg1?
- RG1
- EINECS 244-989-9
- Ginsenoside Rg1 CRS
- Panaxoside A (Standard)
- Ginsenoside Rg1 (Standard)
- BIDD:ER0075
- orb1305031
- orb3140530
- SCHEMBL19875635
- GINSENOSIDE RG1 [USP-RS]
- GINSENOSIDE RG1 [WHO-DD]
- HMS3885M12
- EX-A6784
- HY-N0045
- MSK40042
- Ginsenoside Rg1, analytical standard
- s3923
- AKOS037514672
- CCG-270492
Look up GINSENOSIDE RG1 in the interactive SynDRA portal →